Markowski Investments’s Elevance Health ELV Stock Holding History

Markowski Investments’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.25K	Buy	+11	New	+$4.08K	﹤0.01%	488

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Markowski Investments's ELV Position: Q2 2026 in Review

Markowski Investments opened a new position in Elevance Health (ELV) in Q2 2026: 11 shares worth $4.25K. The stake represents ﹤0.01% of the portfolio and ranks #488 among its holdings.

1,303 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Markowski Investments held 11 shares of Elevance Health worth $4.25K as of Q2 2026.
Elevance Health was a new Markowski Investments position in Q2 2026.
Elevance Health made up ﹤0.01% of Markowski Investments's portfolio in Q2 2026, its #488 holding.
1,303 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Markowski Investments's 13F filing for Q2 2026, filed 13 Aug 2026.